OS Therapies Inc — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
OS Therapies adopted an Amended and Restated 2023 Incentive Compensation Plan, increasing the total share reserve to 15,000,000 shares available for delivery under the plan (including shares previously available under the Prior Plan and shares subject to outstanding awards). The plan covers options, restricted stock, stock appreciation rights, deferred stock, performance awards, and other equity instruments for employees, directors, and consultants. No specific grant amounts, recipient names, or transaction dates are disclosed in this plan document.
Why this rating
Equity plan amendment is routine for small-cap companies; 15M shares at ~$49.6M market cap equals ~30% fully diluted potential dilution. Material to cap table but standard administrative governance act.
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.